151 related articles for article (PubMed ID: 16141758)
21. Menstrual suppression in the adolescent.
Kantartzis KL; Sucato GS
J Pediatr Adolesc Gynecol; 2013 Jun; 26(3):132-7. PubMed ID: 23158755
[TBL] [Abstract][Full Text] [Related]
22. Extended- and continuous-cycle oral contraceptives.
Shrader SP; Dickerson LM
Pharmacotherapy; 2008 Aug; 28(8):1033-40. PubMed ID: 18657019
[TBL] [Abstract][Full Text] [Related]
23. Recent innovations in oral contraception.
Cremer M; Phan-Weston S; Jacobs A
Semin Reprod Med; 2010 Mar; 28(2):140-6. PubMed ID: 20391327
[TBL] [Abstract][Full Text] [Related]
24. The clinical rationale for menses-free contraception.
Lin K; Barnhart K
J Womens Health (Larchmt); 2007 Oct; 16(8):1171-80. PubMed ID: 17937570
[TBL] [Abstract][Full Text] [Related]
25. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives.
Wiegratz I; Hommel HH; Zimmermann T; Kuhl H
Contraception; 2004 Jan; 69(1):37-42. PubMed ID: 14720618
[TBL] [Abstract][Full Text] [Related]
26. Norgestrel, a low dose, oral progestogen for fertility contro. Supplementary report.
Roland M; Friedman M; Hessekiel RJ
Obstet Gynecol; 1968 May; 31(5):637-42. PubMed ID: 5646394
[TBL] [Abstract][Full Text] [Related]
27. A prospective follow-up of two 21/7 cycles followed by two extended regimen 84/7 cycles with contraceptive pills containing ethinyl estradiol and drospirenone.
Seidman DS; Yeshaya A; Ber A; Amodai I; Feinstein I; Finkel I; Gordon N; Porat N; Samuel D; Shiran-Makler E; Wolman I
Isr Med Assoc J; 2010 Jul; 12(7):400-5. PubMed ID: 20862819
[TBL] [Abstract][Full Text] [Related]
28. Real-world experience of women using extended-cycle vs monthly-cycle combined oral contraception in the United States: the National Health and Wellness Survey.
Nappi RE; Lete I; Lee LK; Flores NM; Micheletti MC; Tang B
BMC Womens Health; 2018 Jan; 18(1):22. PubMed ID: 29347935
[TBL] [Abstract][Full Text] [Related]
29. Attitudes and prescribing preferences of health care professionals in the United States regarding use of extended-cycle oral contraceptives.
Sulak PJ; Buckley T; Kuehl TJ
Contraception; 2006 Jan; 73(1):41-5. PubMed ID: 16371293
[TBL] [Abstract][Full Text] [Related]
30. [Extended cycle oral contraceptives].
Geist R; Beyth Y
Harefuah; 2007 Oct; 146(10):781-4, 813. PubMed ID: 17990394
[TBL] [Abstract][Full Text] [Related]
31. [Menstrual bleeding -- must that be? Extended use of oral hormonal contraceptives].
Göretzlehner G
Zentralbl Gynakol; 2005 Oct; 127(5):302-7. PubMed ID: 16195974
[TBL] [Abstract][Full Text] [Related]
32. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Akerlund M; Røde A; Westergaard J
Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
[TBL] [Abstract][Full Text] [Related]
33. Managing menstrual disturbances.
Barnett B
Netw Res Triangle Park N C; 1995 Jun; 15(4):8. PubMed ID: 12289833
[TBL] [Abstract][Full Text] [Related]
34. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M
Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
[TBL] [Abstract][Full Text] [Related]
35. Mayo Clinic office visit. Menstrual manipulation.
Abboud R
Mayo Clin Womens Healthsource; 2003 Dec; 7(12):suppl 1-2. PubMed ID: 14639254
[No Abstract] [Full Text] [Related]
36. Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials.
Edelman A; Gallo MF; Nichols MD; Jensen JT; Schulz KF; Grimes DA
Hum Reprod; 2006 Mar; 21(3):573-8. PubMed ID: 16489210
[TBL] [Abstract][Full Text] [Related]
37. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
Nappi C; Farace MJ; Leone F; Minutolo M; Tommaselli AP; Montemagno U
Eur J Obstet Gynecol Reprod Biol; 1987 Jul; 25(3):209-19. PubMed ID: 2956138
[TBL] [Abstract][Full Text] [Related]
38. [To bleed or not--a new dogma or a real choice in contraception?].
Renteria SC
Rev Med Suisse; 2008 Oct; 4(176):2246-50, 2252. PubMed ID: 19025174
[TBL] [Abstract][Full Text] [Related]
39. Communicating with patients about extended-cycle and continuous use of oral contraceptives.
Nelson AL
J Womens Health (Larchmt); 2007 May; 16(4):463-70. PubMed ID: 17521249
[TBL] [Abstract][Full Text] [Related]
40. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
Barbosa IC; Filho CI; Faggion D; Baracat EC
Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
